Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Robert W Hallowell"'
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31299 (2012)
Pulmonary fibrosis is an untreatable, uniformly fatal disease of unclear etiology that is the result of unremitting chronic inflammation. Recent studies have implicated bone marrow derived fibrocytes and M2 macrophages as playing key roles in propaga
Externí odkaz:
https://doaj.org/article/577ea467bc9c4a77b97e1b2aeb2f5104
Autor:
Dane A, Fisher, Mark C, Murphy, Sydney B, Montesi, Lida P, Hariri, Robert W, Hallowell, Florence K, Keane, Michael, Lanuti, Meghan J, Mooradian, Florian J, Fintelmann
Publikováno v:
Radiologic Clinics of North America. 60:993-1002
Interstitial lung disease (ILD) including idiopathic pulmonary fibrosis increases the risk of developing lung cancer. Diagnosing and staging lung cancer in patients with ILD is challenging and requires careful interpretation of computed tomography (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa6ac0b1ad57b8560cc0ae25a959a121
https://doi.org/10.1016/j.rcl.2022.06.010
https://doi.org/10.1016/j.rcl.2022.06.010
Publikováno v:
Respiratory Medicine Case Reports, Vol 27, Iss , Pp - (2019)
Immune checkpoint inhibitors are known to cause a variety of immune-related adverse events, including pneumonitis. When symptomatic, treatment typically consists of temporary or permanent cessation of the checkpoint inhibitor and several weeks of cor
Externí odkaz:
https://doaj.org/article/27da89c6fba448568ad2a280f1be5024
Autor:
Robert W. Hallowell, Sonye K. Danoff
Publikováno v:
Chest.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7390f10a981e1046cb04ca028f6d62a
https://doi.org/10.1016/j.chest.2023.01.031
https://doi.org/10.1016/j.chest.2023.01.031
Autor:
Benjamin Lloyd, William B. Kimmel, Urvi Patel, Anthony A. Donato, Robert W. Hallowell, Caitlyn Moss, Christian Akem Dimala
Publikováno v:
Case Reports in Pulmonology, Vol 2021 (2021)
Case Reports in Pulmonology
Case Reports in Pulmonology
Fewer than ten reported cases of cryptogenic organizing pneumonia (COP) have been managed with intravenous immunoglobulins (IVIg). We report a case of a 72-year-old man who presented with a worsening cough and diffuse opacities on chest radiograph. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffca11f84d3024d3715de35b68cc60c
https://doi.org/10.1155/2021/9343491
https://doi.org/10.1155/2021/9343491
Autor:
George T. O'Connor, Robert W. Hallowell, Cyrus A. Kholdani, Gary M. Hunninghake, George R. Washko, Mary B. Rice, Murray A. Mittleman, Raul San Jose Estepar, Andrew J. Synn, Alexander A. Bankier, Wenyuan Li
Publikováno v:
Chest. 159:663-672
Pulmonary vascular disease is associated with poor outcomes in individuals affected by interstitial lung disease. The pulmonary vessels can be quantified with noninvasive imaging, but whether radiographic indicators of vasculopathy are associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423465d5ecc002298a5621c556851a92
https://doi.org/10.1016/j.chest.2020.07.082
https://doi.org/10.1016/j.chest.2020.07.082
Autor:
Alyssa Soskis, Robert W. Hallowell
Publikováno v:
Respiration. 100:923-932
Interstitial lung disease (ILD) is a cause of substantial morbidity and mortality amongst autoimmune diseases, including myositis. Despite first-line therapy with immunosuppression, many inflammatory ILDs advance to a fibrotic stage. In such patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9434a901100e9a69c70ee3fb4bce779f
https://doi.org/10.1159/000515607
https://doi.org/10.1159/000515607
Publikováno v:
Respiratory medicine. 191
We aimed to determine if antibody type is an indicator of pulmonary histopathology, using antisynthetase antibody positive interstitial lung disease (ILD) cases with lung biopsy or autopsy findings.We conducted a comprehensive review of the English l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f285f672ed023b85c89393e83fa26b1
https://pubmed.ncbi.nlm.nih.gov/34864634
https://pubmed.ncbi.nlm.nih.gov/34864634
Publikováno v:
Chest. 160(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f976e722ed1e83df2bfc4ec3f0ec13
https://pubmed.ncbi.nlm.nih.gov/34872690
https://pubmed.ncbi.nlm.nih.gov/34872690
Autor:
Robert B. Banzett, Carl R. O'Donnell, Andrew R. Sheridan, Robert W. Hallowell, Richard M. Schwartzstein
Publikováno v:
Lung. 198:113-120
Aerosol furosemide may be an option to treat refractory dyspnea, though doses, methods of delivery, and outcomes have been variable. We hypothesized that controlled delivery of high dose aerosol furosemide would reduce variability of dyspnea relief i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94faf68dc02afca01281f7d10eebdde9
https://doi.org/10.1007/s00408-019-00292-7
https://doi.org/10.1007/s00408-019-00292-7